Isohomohalichondrin BAlternative Names: IHB; Isohomohalicondium
Latest Information Update: 07 Oct 2004
At a glance
- Originator PharmaMar
- Class Antineoplastics; Pyrans; Spiro compounds
- Mechanism of Action Tubulin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Oct 2004 Discontinued - Preclinical for Cancer in Spain (unspecified route)
- 06 Sep 2002 This compound is still in active development
- 05 Sep 1996 Preclinical development for Cancer in Spain (Unknown route)